ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 98 filers reported holding ADMA BIOLOGICS INC in Q2 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $587,800 | -4.9% | 164,190 | -2.0% | 0.00% | 0.0% |
| Q2 2023 | $618,322 | +5.8% | 167,567 | -5.1% | 0.00% | 0.0% |
| Q1 2023 | $584,165 | -22.6% | 176,485 | -9.3% | 0.00% | 0.0% |
| Q4 2022 | $754,792 | +137.4% | 194,534 | +79.3% | 0.00% | +100.0% |
| Q2 2020 | $318,000 | +1.9% | 108,500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $312,000 | +90.2% | 108,500 | +164.6% | 0.00% | – |
| Q4 2019 | $164,000 | -9.9% | 41,000 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $182,000 | +76.7% | 41,000 | +54.1% | 0.00% | – |
| Q2 2019 | $103,000 | +4.0% | 26,600 | +2.3% | 0.00% | – |
| Q1 2019 | $99,000 | +106.2% | 26,000 | +30.0% | 0.00% | – |
| Q4 2018 | $48,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,608,171 | $8,624,000 | 2.44% |
| Broadfin Capital, LLC | 4,226,077 | $10,100,000 | 1.33% |
| MORGENS WATERFALL VINTIADIS & CO INC | 400,000 | $956,000 | 0.85% |
| Consonance Capital Management LP | 4,588,352 | $10,966,000 | 0.81% |
| Perceptive Advisors | 6,521,102 | $14,542,000 | 0.55% |
| Diag Capital Management, LP | 182,100 | $435,000 | 0.50% |
| 683 Capital Management, LLC | 805,000 | $1,924,000 | 0.12% |
| ARDSLEY ADVISORY PARTNERS LP | 50,000 | $120,000 | 0.03% |
| AVANTAX ADVISORY SERVICES, INC. | 65,050 | $156,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 37,170 | $89,000 | 0.02% |